-
Part 2 | Session 1 Stroke Management After AF Ablation
-
Part 2 | Session 2 VOLT AF IDE
-
Part 2 | Session 3 VERITAS Study: Next-Generation LAA Closure with Amulet 360
-
Part 2 | Session 4 STYLE AF Update: Venous Vascular Closure in AF Patients
-
Part 2 | Session 5 Balloon-in-Basket PFA without Propofol
-
Part 2 | Session 6 ADVENT LTO: Long-Term PFA Outcomes and AF Progression
-
Part 3 | Session 1 4 Trials That Will Change My Practice with Dr Luigi Di Biase
-
Part 3 | Session 2 AF & EP in 2026: Five Things That Will Change Daily Practice
-
Part 1 | Session 1 Complication Prevention in Complex AF and VT Procedures
-
Part 1 | Session 2 Will PFA Redefine AF Ablation Strategies in 2026?
AF Symposium 2026 - Repeat ablation strategies: Moving Beyond Pulmonary Vein Isolation and the Role of Advanced Mapping.
Dr Boris Schmidt (Cardioangiologisches Centrum Bethanien, Frankfurt, DE) and Dr Atul Verma (McGill University Health Centre & McGill University, Montreal, CA, US) discuss optimal approaches to redo atrial fibrillation ablation and the critical decision of when to extend beyond pulmonary vein isolation. The conversation explores strategies for identifying pulmonary vein reconnection, evaluating substrate modification techniques, and determining which patients may benefit from additional lesion sets beyond repeat PVI.
The discussion examines the common clinical scenario where pulmonary veins are found to be already isolated during a redo procedure, necessitating a move toward substrate-based mapping. The experts discuss the transition from empirical approaches to individualised strategies, such as targeting low-voltage areas and late atrial potentials identified while the patient is in sinus rhythm. They also evaluate the technical challenges of achieving bidirectional conduction block in linear lesions and how newer technologies, like dual-energy catheters and ethanol infusion, are shifting the procedural landscape.
Recorded on-site at AF Symposium 2026.
Editor: Jordan Rance
Videographer: Tom Green
Support: This is an independent interview produced by Radcliffe Cardiology.
Stay up to date with our video collection covering late-breaking data from AF Symposium 2026 in Boston. Don't miss our short, accessible Expert Interviews, Discussions and Highlights of the most pertinent trials.
More from this programme
Part 1
Clinical Discussions
Part 2
Expert Interviews
Faculty Biographies
Boris Schmidt
Cardiologist
Dr Boris Schmidt is a Cardiologist specialising in Electrophysiology at Cardiologisches Centrum Bethanien in Frankfurt, Germany. Dr Boris Schmidt's scientific activities are focused on catheter ablation of atrial fibrillation and the development of novel single-shot technologies as well as interventional stroke prophylaxis.
Atul Verma
Director of Cardiology
Dr Atul Verma is currently Director of Cardiology at the McGill University Health Centre & McGill University, Montreal, CA.
Specialising in complex arrhythmias like atrial fibrillation and ventricular tachycardia, he has published over 300 peer-reviewed articles including in The New England Journal of Medicine. Dr Verma has co-chaired the Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee and contributed to the HRS/EHRA Consensus Document on Catheter Ablation of Atrial Fibrillation. He currently leads and participates in multiple international clinical trials.
Comments